Jackson Taylor Therapeutics, Inc.

An AI Genomics & Therapeutics firm focused on mapping the Human Genome for People of Color to remove health disparities.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Wilmington, DE, USA
  • Currency USD
  • Founded March 2023
  • Employees 2
  • Incorporation Type C-corp
  • Website NA

Company Summary

We are sequencing the Human Genome for People of Color; developing/commercializing biologic drugs to treat diseases/viruses that significantly impact People of Color most; and providing a pathway to close the wealth gap within minority communities by building a sustainable Informed Consent program that allows Research Participants to generate revenue from their genetic donations via both short-term/long-term U.S. Currency Payment Opportunities.

Team

  • Dr. Tia Lyles-Williams, D.Sc.
    Founder & CEO

    A 3x Life Science Start-Up Founder / Bio-Manufacturing Executive with 22+ years of Commercial Life Science experience - including cGLP Laboratory Operations, cGMP Bioprocessing Operations, Drug Commercialization, and Global Regulatory Affairs. Dr.Tia is also an alum of Howard University (BSc.), Full Sail University, (M.S.) and University Southern California (MRSc.). Her former employers include the U.S. Federal Government and Big Pharma.

  • Dr. Chardae Rodgers-Gamble
    Co-Founder & Chief Research Officer

    Dr. Chardae Rodgers-Gamble is the owner of CR Clinical - #1 CRO in the Philadelphia Region. Dr. Gamble is a Clinical Operations Professional with +12 years experience in clinical research. She has worked as a Clinical Research Associate, Clinical Trial Manager, Clinical Project Manager & Clinical Project Lead along w/ providing pharma companies and CROs with full clinical research services.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free